Edward K. Dziadulewicz
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Blood Coagulation and Thrombosis Mechanisms, Peptidase Inhibition and Analysis, Synthesis of heterocyclic compounds, Synthesis and Reactivity of Sulfur-Containing Compounds
Most-Cited Works
- → Synthesis of Nonproteinogenic (R)‐ or (S)‐Amino Acids Analogues of Phenylalanine, Isotopically Labelled and Cyclic Amino Acids from tert‐Butyl 2‐(tert‐Butyl)‐3‐methyl‐4‐oxo‐1‐imidazolidinecarboxylate (Boc‐BMI)(1989)119 cited
- → Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia(2000)104 cited
- → Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A Potent, Orally Bioavailable Human CB1/CB2Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration(2007)96 cited
- → Identification and Biological Characterization of 6-Aryl-7-isopropylquinazolinones as Novel TRPV1 Antagonists that Are Effective in Models of Chronic Pain(2005)59 cited
- → The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold(1999)57 cited
- → Nausea and vomiting of pregnancy and resource implications: the NVP Impact Study(2018)38 cited
- → Mitsunobu alkylation of imidazole: a convenient route to chiral ionic liquids(2004)36 cited
- → Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease(2010)35 cited
- → A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B1 Receptor(2006)33 cited
- → Potent and Orally Bioavailable Non-Peptide Antagonists at the Human Bradykinin B1 Receptor Based on a 2-Alkylamino-5-sulfamoylbenzamide Core(2004)28 cited